Improvement of HbA1c and LDL-C by Imeglimin (Twymeeg) in the Diabetic Female Elderly Continue ReadingImprovement of HbA1c and LDL-C by Imeglimin (Twymeeg) in the Diabetic Female Elderly
Clinically Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RA) with Related Factors | Abstract Continue ReadingClinically Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RA) with Related Factors | Abstract
Recent Research Development of Imeglimin as Oral Hypoglycemic Agent (OHA) | Abstract Continue ReadingRecent Research Development of Imeglimin as Oral Hypoglycemic Agent (OHA) | Abstract
Detail Measurement of Pre-Prandial and Post-Prandial Blood Glucose during Imeglimin (Twymeeg) Treatment | Abstract Continue ReadingDetail Measurement of Pre-Prandial and Post-Prandial Blood Glucose during Imeglimin (Twymeeg) Treatment | Abstract
